HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alexander, G. E. Articles by Moses, H. Search for Related Content PubMed PubMed Citation Articles by Alexander, G. E. Articles by Moses, H., III

Carbamazepine for hemi facial spasm

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.

Carbamazepine in daily doses of 600 to 1200 mg controlled hemi facial spasm in three patients. In other reports, carbamazepine was effective in over half of the patients. Controlled trials are needed to established whether Carbamazepine is as effective as the surgical therapies currently in vogue.

Address correspondence and reprint requests to Dr. Alexander, Department of Neurology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21205.

Accepted for publication August 17, 1981.

This article has been cited by other articles:

				N.-C. TAN, L.-L. CHAN, and E.-K. TAN Hemifacial spasm and involuntary facial movements QJM, August 1, 2002; 95(8): 493 - 500. [Abstract] [Full Text] [PDF]

				A. W. Biglan, M. May, and R. A. Bowers Management of Facial Spasm With Clostridium botulinum Toxin, Type A (Oculinum) Arch Otolaryngol Head Neck Surg, December 1, 1988; 114(12): 1407 - 1412. [Abstract] [PDF]